Genomic alterations as mediators of miRNA dysregulation in ovarian cancer-Reference-Cited by-同舟云学术

Genomic alterations as mediators of miRNA dysregulation in ovarian cancer

Published:2014-10-03 Issue:1 Volume:54 Page:1-19
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Kan Casina W. S.¹,Howell Viive M.¹,Hahn Michael A.¹,Marsh Deborah J.¹

Affiliation:

1. Hormones and Cancer Group; Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital; St Leonards Sydney NSW 2065 Australia

Funder

Australian Research Council

National Health and Medical Research Council

Cancer Council NSW

Australian Postgraduate Award

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference209 articles.

1. Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients;Aghili;Cell Rep,2014

2. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary;Ahmed;J Pathol,2010

3. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian Ovarian Cancer Study Group;Alsop;J Clin Oncol,2012

4. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

5. p53: Guardian of ploidy;Aylon;Mol Oncol,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-5590-3p inhibits the proliferation and invasion of ovarian cancer cells through mediating the Wnt/βcatenin signaling pathway by targeting TNIK;HISTOL HISTOPATHOL;2024

2. miRNA on the Battlefield of Cancer: Significance in Cancer Stem Cells, WNT Pathway, and Treatment;Cancers;2024-02-27

3. Relationship between NUDT21 mediated alternative polyadenylation process and tumor;Frontiers in Oncology;2023-02-02

4. Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine;Genes & Diseases;2022-11

5. MicroRNA‐378a‐3p contributes to ovarian cancer progression through downregulating PDIA4;Immunity, Inflammation and Disease;2020-11-07